Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel

Tomasz M. Beer, Celestia S. Higano, Mansoor Saleh, Robert Dreicer, Gary Hudes, Joel Picus, Mark Rarick, Louis Fehrenbacher, Alison L. Hannah

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel'. Together they form a unique fingerprint.

Medicine & Life Sciences